by Katrina Carr | Apr 11, 2019 | Diagnosis & Therapy
New Approaches to Small Cell Lung Cancer Therapy Reported by Neil Osterweil Videography by Patrick Frank MDedge News New Approaches to Small Cell Lung Cancer Therapy Small-cell lung cancer (SCLC) is an extremely aggressive pulmonary malignancy with 5-year overall...
by Katrina Carr | Apr 11, 2019 | Diagnosis & Therapy
Clinical Trials Chip Away at Small-Cell Lung Cancer Defenses Reported by Neil Osterweil MDedge News Clinical Trials Chip Away at Small-Cell Lung Cancer Defenses Small-cell lung cancer (SCLC), in the words of one leading oncologist, is the “type of disease that gives...
by mzeal | Apr 2, 2019 | Diagnosis & Therapy
Vaccine may restore NSCLC response to checkpoint inhibitors BY CHRISTINE KILGORE MDedge News SAN FRANCISCO – An experimental allogeneic cellular vaccine combined with the checkpoint inhibitor nivolumab (Opdivo) may boost the immune response in patients with previously...
by mzeal | Apr 1, 2019 | Diagnosis & Therapy
Neoadjuvant atezolizumab shrinks NSCLC tumors BY CHRISTINE KILGORE MDedge News SAN FRANCISCO – One-fifth of patients with resectable non–small cell lung cancer had a major pathologic response to neoadjuvant therapy with the immune checkpoint inhibitor atezolizumab...
by mzeal | Apr 1, 2019 | Diagnosis & Therapy
Interview with Roy S. Herbst, MD, PhD, on Immunotherapy in Lung Cancer BY CHRISTINE KILGORE MDedge News Roy S. Herbst, MD, PhD, is the Ensign Professor of Medicine (Medical Oncology) and Professor of Pharmacology at Yale University, and Chief of Medical Oncology at...
